Results 221 to 230 of about 102,708 (355)

AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers [PDF]

, 2007
Yuki Moritoki, Zhe‐Xiong Lian, Heike Wulff, Guo–Xiang Yang, Ya‐Hui Chuang, Ruth Y. Lan, Yoshiyuki Ueno, Aftab A. Ansari, Ross L. Coppel, Lauren Grace Mackey, Eric M. Gershwin   +10 more
openalex   +1 more source

Machine Learning Approach Enables Highly Accurate Identification of At‐Risk Metabolic Dysfunction‐Associated Steatohepatitis

Hepatology Research, EarlyView.
ABSTRACT Aim At‐risk metabolic dysfunction‐associated steatohepatitis (MASH), characterized by significant activity and fibrosis, increases the risk of liver complications. Liver stiffness measurement (LSM), commonly used to detect significant fibrosis, has limitations in terms of accessibility and performance in certain populations.
Masaya Sato, Takuma Nakatsuka, Tatsuya Minami, Yotaro Kudo, Rie Irie, Hanako Tsujikawa, Takumi Kawaguchi, Hirokazu Takahashi, Yuichiro Eguchi, Eisuke Murakami, Kazuaki Chayama, Takeshi Okanoue, Michiie Sakamoto, Mitsuhiro Fujishiro, Kazuhiko Koike, Ryosuke Tateishi   +15 more
wiley   +1 more source

A case of hepatic pseudolymphoma in a patient with primary biliary cirrhosis. [PDF]

Clin Case Rep, 2019
Inoue M, Tanemura M, Yuba T, Miyamoto T, Yamaguchi M, Irei T, Seo S, Misumi T, Shimizu W, Suzuki T, Onoe T, Sudo T, Shimizu Y, Hinoi T, Tashiro H.   +14 more
europepmc   +1 more source

Primary biliary cirrhosis: Prediction of short-term survival based on repeated patient visits [PDF]

, 1994
Paul A. Murtaugh
openalex   +1 more source

Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C Patients

Hepatology Research, EarlyView.
ABSTRACT Background and Aims Glecaprevir/pibrentasvir (GLE/PIB) and sofosbuvir/ledipasvir (SOF/LDV) are widely used as first‐line direct‐acting antiviral (DAA) regimens for chronic hepatitis C, achieving high virus eradication rates. However, a small proportion of patients experience treatment failure, and the optimal retreatment strategies for such ...
Nobuharu Tamaki, Masayuki Kurosaki, Hironori Ochi, Hideki Fujii, Yuichiro Suzuki, Takuya Sho, Hayato Hikita, Hiroyuki Marusawa, Yasuhiro Asahina, Namiki Izumi, Tatsuya Kanto   +10 more
wiley   +1 more source

Multiple Periapical Lesions Influence the Expression of TLR4/NF‐κB Pathway Components and the Development of Hepatic Injuries in Healthy and Chronic Alcohol‐Consuming Rats

International Endodontic Journal, EarlyView.
ABSTRACT Aim To evaluate the impact of multiple apical periodontitis (AP) on the expression of TLR4/NF‐κB pathway components, proinflammatory cytokine levels, and development of hepatic injuries in rats with and without chronic alcohol consumption. Methodology Thirty‐two rats were assigned to four groups (n = 8): Control, AP, Alcohol, and Alcohol+AP ...
Karem Paula Pinto, Isabelle da Cunha Degani, Jenif Braga de Souza, Renata Heisler Neves, Luciana Brandão‐Bezerra, Luciana Moura Sassone, Emmanuel João Nogueira Leal da Silva   +6 more
wiley   +1 more source

Primary biliary cirrhosis with refractory hypokalemia: A case report. [PDF]

Medicine (Baltimore), 2018
Dong KH, Fang YN, Wen XY, Jin QL.
europepmc   +1 more source

Diffuse Systemic Sclerosis in a Patient with Primary Biliary Cirrhosis and Autoimmune Hepatitis Overlap Syndrome: A Case Report. [PDF]

Ann Dermatol, 2020
Han HS, Ahn GR, Kim HJ, Park KY, Li K, Seo SJ.   +5 more
europepmc   +1 more source

Tu1004 Ursodeoxycholic Acid Therapy Improves Survival of Non-Caucasian Patients With Primary Biliary Cirrhosis With Limited Liver Transplantation Availability

, 2013
Yazmín Karel Melchor-Mendoza, Segundo Morán, Aline Mina Hawat, Gustavo Arturo Rodríguez-Leal, Aldo Torre, Misael Uribe   +5 more
openalex   +1 more source

Lymphocyte transformation in response to phytohaemagglutinin in primary biliary cirrhosis: The search for a plasma inhibitory factor [PDF]

, 1973
Roy Fox, F. J. Dudley, M. L. Samuels, James A. Milligan, S. Sherlock   +4 more
openalex   +1 more source